vs
FARMERS NATIONAL BANC CORP（FMNB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
FARMERS NATIONAL BANC CORP的季度营收约是RIGEL PHARMACEUTICALS INC的1.0倍（$71.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 20.5%，领先363.6%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 3.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 6.2%）
Farmers National Banc Corp（俄亥俄州）是总部位于美国俄亥俄州的地区性金融控股公司，提供零售及商业银行、财富管理、保险等多元服务，主要服务俄亥俄州及美国中西部邻近区域的个人、中小企业与本地社区客户。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
FMNB vs RIGL — 直观对比
营收规模更大
FMNB
是对方的1.0倍
$69.8M
营收增速更快
RIGL
高出18.0%
3.2%
净利率更高
RIGL
高出363.6%
20.5%
两年增速更快
RIGL
近两年复合增速
6.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $71.5M | $69.8M |
| 净利润 | $14.6M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 24.8% | 33.2% |
| 净利率 | 20.5% | 384.0% |
| 营收同比 | 3.2% | 21.2% |
| 净利润同比 | 1.7% | 1769.2% |
| 每股收益（稀释后） | $0.39 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMNBRIGL
| Q4 25 | $71.5M | $69.8M | ||
| Q3 25 | $70.8M | $69.5M | ||
| Q2 25 | $69.8M | $101.7M | ||
| Q1 25 | $67.8M | $53.3M | ||
| Q4 24 | $69.3M | $57.6M | ||
| Q3 24 | $70.3M | $55.3M | ||
| Q2 24 | $66.5M | $36.8M | ||
| Q1 24 | $63.4M | $29.5M |
净利润FMNBRIGL
| Q4 25 | $14.6M | $268.1M | ||
| Q3 25 | $12.5M | $27.9M | ||
| Q2 25 | $13.9M | $59.6M | ||
| Q1 25 | $13.6M | $11.4M | ||
| Q4 24 | $14.4M | $14.3M | ||
| Q3 24 | $8.5M | $12.4M | ||
| Q2 24 | $11.8M | $-1.0M | ||
| Q1 24 | $11.2M | $-8.2M |
毛利率FMNBRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率FMNBRIGL
| Q4 25 | 24.8% | 33.2% | ||
| Q3 25 | 20.7% | 40.9% | ||
| Q2 25 | 23.4% | 60.1% | ||
| Q1 25 | 24.1% | 23.9% | ||
| Q4 24 | 25.5% | 28.9% | ||
| Q3 24 | 14.4% | 25.4% | ||
| Q2 24 | 21.3% | 1.2% | ||
| Q1 24 | 21.2% | -23.6% |
净利率FMNBRIGL
| Q4 25 | 20.5% | 384.0% | ||
| Q3 25 | 17.6% | 40.2% | ||
| Q2 25 | 19.9% | 58.6% | ||
| Q1 25 | 20.0% | 21.5% | ||
| Q4 24 | 20.8% | 24.9% | ||
| Q3 24 | 12.1% | 22.5% | ||
| Q2 24 | 17.7% | -2.8% | ||
| Q1 24 | 17.7% | -27.9% |
每股收益（稀释后）FMNBRIGL
| Q4 25 | $0.39 | $14.11 | ||
| Q3 25 | $0.33 | $1.46 | ||
| Q2 25 | $0.37 | $3.28 | ||
| Q1 25 | $0.36 | $0.63 | ||
| Q4 24 | $0.38 | $0.82 | ||
| Q3 24 | $0.23 | $0.70 | ||
| Q2 24 | $0.31 | $-0.06 | ||
| Q1 24 | $0.30 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $86.7M | $52.5M |
| 股东权益账面价值 | $485.7M | $391.5M |
| 总资产 | $5.2B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.18× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资FMNBRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务FMNBRIGL
| Q4 25 | $86.7M | $52.5M | ||
| Q3 25 | $86.6M | $60.0M | ||
| Q2 25 | $86.4M | $60.0M | ||
| Q1 25 | $86.3M | $60.0M | ||
| Q4 24 | $86.2M | $60.0M | ||
| Q3 24 | $86.0M | $60.0M | ||
| Q2 24 | $88.9M | $60.0M | ||
| Q1 24 | $88.8M | $60.0M |
股东权益FMNBRIGL
| Q4 25 | $485.7M | $391.5M | ||
| Q3 25 | $465.9M | $117.6M | ||
| Q2 25 | $437.7M | $81.9M | ||
| Q1 25 | $429.1M | $18.6M | ||
| Q4 24 | $406.0M | $3.3M | ||
| Q3 24 | $439.7M | $-14.6M | ||
| Q2 24 | $396.7M | $-29.9M | ||
| Q1 24 | $397.0M | $-31.7M |
总资产FMNBRIGL
| Q4 25 | $5.2B | $513.6M | ||
| Q3 25 | $5.2B | $242.5M | ||
| Q2 25 | $5.2B | $206.7M | ||
| Q1 25 | $5.2B | $176.0M | ||
| Q4 24 | $5.1B | $164.0M | ||
| Q3 24 | $5.2B | $139.4M | ||
| Q2 24 | $5.2B | $128.4M | ||
| Q1 24 | $5.1B | $126.5M |
负债/权益比FMNBRIGL
| Q4 25 | 0.18× | 0.13× | ||
| Q3 25 | 0.19× | 0.51× | ||
| Q2 25 | 0.20× | 0.73× | ||
| Q1 25 | 0.20× | 3.23× | ||
| Q4 24 | 0.21× | 18.25× | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.22× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $52.2M | — |
| 自由现金流率自由现金流/营收 | 73.0% | — |
| 资本支出强度资本支出/营收 | 11.0% | — |
| 现金转化率经营现金流/净利润 | 4.10× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $85.8M | — |
8季度趋势，按日历期对齐
经营现金流FMNBRIGL
| Q4 25 | $60.0M | $22.0M | ||
| Q3 25 | $10.7M | $24.0M | ||
| Q2 25 | $14.0M | $30.5M | ||
| Q1 25 | $15.7M | $-893.0K | ||
| Q4 24 | $66.6M | $14.5M | ||
| Q3 24 | $23.9M | $21.7M | ||
| Q2 24 | $16.6M | $302.0K | ||
| Q1 24 | $13.7M | $-5.0M |
自由现金流FMNBRIGL
| Q4 25 | $52.2M | — | ||
| Q3 25 | $9.0M | — | ||
| Q2 25 | $12.4M | — | ||
| Q1 25 | $12.2M | — | ||
| Q4 24 | $54.9M | — | ||
| Q3 24 | $20.4M | — | ||
| Q2 24 | $14.4M | — | ||
| Q1 24 | $12.2M | — |
自由现金流率FMNBRIGL
| Q4 25 | 73.0% | — | ||
| Q3 25 | 12.8% | — | ||
| Q2 25 | 17.8% | — | ||
| Q1 25 | 18.0% | — | ||
| Q4 24 | 79.2% | — | ||
| Q3 24 | 29.1% | — | ||
| Q2 24 | 21.6% | — | ||
| Q1 24 | 19.2% | — |
资本支出强度FMNBRIGL
| Q4 25 | 11.0% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 5.2% | — | ||
| Q4 24 | 16.9% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 2.4% | — |
现金转化率FMNBRIGL
| Q4 25 | 4.10× | 0.08× | ||
| Q3 25 | 0.86× | 0.86× | ||
| Q2 25 | 1.01× | 0.51× | ||
| Q1 25 | 1.15× | -0.08× | ||
| Q4 24 | 4.63× | 1.01× | ||
| Q3 24 | 2.80× | 1.75× | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | 1.22× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
